Find Federal Grants
Fertility and Fertility Preservation for Patients with Diseases that Previously Precluded Reproduction (R21 Clinical Trial Optional)
National Institutes of Health · RFA-HD-20-021
Data Sharing for Demographic Research Infrastructure Program (R24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-HD-20-001
Limited Competition: AIDS Malignancy Consortium (AMC) (UM1 Clinical Trials Required)
National Institutes of Health · RFA-CA-19-056
Advancing Sustained/Extended Release for HIV Prevention (A-SER) (R01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AI-19-063
Resource-Related Research Projects for Development of Animal Models and Related Materials (R24 Clinical Trials Not-Allowed)
National Institutes of Health · RFA-OD-19-027
Tailoring Interventions to Improve Preventive Health Service Use (R61/R33 Clinical Trial Required)
National Institutes of Health · RFA-AG-20-045
Orphans and Vulnerable Children
Mozambique USAID-Maputo · 72065619RFA00012
Centers for Disease Control - NCHHSTP · CDC-RFA-PS20-2003
Health Resources and Services Administration · HRSA-20-085
Office of the Assistant Secretary for Health · PA-TPE-20-001
Office of the Assistant Secretary for Health · PA-TP1-20-001
FY2020 Teen Pregnancy Prevention (TPP) Tier 2, Phase II Rigorous Evaluation of Promising Interventions
Office of the Assistant Secretary for Health · PA-TP2-20-001
Tier 2 Innovation and Impact Network Grants: Achieving Optimal Health and Preventing Teen Pregnancy in Key Priority Areas
Office of the Assistant Secretary for Health · PA-TP2-20-002
Social Epigenomics Research Focused on Minority Health and Health Disparities (R01-Clinical Trial Not Allowed)
National Institutes of Health · PAR-19-372
National Institutes of Health · PAR-19-371
Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)
National Institutes of Health · PAR-19-369
Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
National Institutes of Health · PAR-19-365
Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
National Institutes of Health · RFA-HL-20-022
Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
National Institutes of Health · RFA-HL-20-023
Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed)
National Institutes of Health · RFA-HL-20-028